Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
NCT00004557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650
Last updated 2008-03-04
Summary
Patients with Alzheimer's disease (AD) perform poorly on tasks dependent on access to, and utilization of, previously acquired knowledge and skills. It has been commonly assumed that impaired knowledge in AD, as well as in other patients with cortical lesions, is due to an actual loss or disorganization of a specific knowledge base or system. This hypothesis has, however, recently been called into question by data from tasks that purport to tap knowledge on a more automatic and implicit level. For example, although AD patients are impaired on object naming and verbal fluency tasks, they show a normal pattern of semantic facilitation on reaction time based priming tasks. In fact, the level of facilitation or activation on these tasks has often been reported to be greater in AD patients than in normal individuals. These and similar data have been used to support arguments that performance decrements in AD patients are due to deficits in attentional and/or retrieval processes rather than a degradation of knowledge stores. The central focus of this project will be to test a model of the semantic representations of object that predicts increased facilitation or hyperpriming in AD patients as a result of degraded representations. The relationship between performance on on-line priming tasks, visual attention and spatial processes, and explicit and implicit measures of memory also will be examined. In addition to normal controls, patients with cognitive and memory impairments, but without semantically-based naming difficulties (elderly depressed, Huntington's disease, Korsakoff's disease) will serve as controls for overall slowness of response and degree of explicit memory deficit.
Conditions
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1992-01-31
- Completion
- 2000-04-30
Countries
- United States
Study Locations
More Related Trials
-
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
NCT04576793 ·Status: RECRUITING ·Phase: PHASE2
-
Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil
NCT01845636 ·Status: COMPLETED ·Phase: PHASE4
-
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
NCT03019757 ·Status: RECRUITING
-
The Effect of Acetylcholine on Memory and Attention
NCT00001977 ·Status: COMPLETED
-
Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
NCT00523666 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4
-
Examining Neuroinflammation in AlzHeimer's
NCT03548883 ·Status: COMPLETED
-
Applying PET/MR for Dementia Applications
NCT04154254 ·Status: UNKNOWN ·Phase: NA
-
Wake Forest Alzheimer's Disease Clinical Core
NCT03140865 ·Status: RECRUITING
-
Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
NCT00065169 ·Status: COMPLETED ·Phase: NA
-
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
NCT02860338 ·Status: COMPLETED
-
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
NCT00255086 ·Status: COMPLETED ·Phase: PHASE3
-
ADRC Clinical Cohort (Alzheimer's Disease)
NCT06703541 ·Status: RECRUITING
-
Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
NCT02087865 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT05552157 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
NCT02854917 ·Status: COMPLETED
-
The Mechanism of MicroRNAs Network in Alzheimer's Disease
NCT05055310 ·Status: COMPLETED
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
NCT04111211 ·Status: COMPLETED
-
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
NCT03938870 ·Status: COMPLETED
-
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161 ·Status: COMPLETED ·Phase: PHASE4
-
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
NCT03136679 ·Status: COMPLETED
-
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
NCT00855868 ·Status: COMPLETED ·Phase: PHASE2
-
Apathy Associated With Alzheimer's Disease
NCT00254033 ·Status: COMPLETED ·Phase: PHASE4